Japanese startup Anges Inc. announced the beginning of clinical trials in humans of a potential vaccine against coronavirus COVID-19. This reports the Kyodo News.
Testing will be conducted at the University hospital of Osaka will start in early July with the introduction of the vaccine in 30 healthy adults. After eight weeks, scientists will assess the condition of the volunteers to find out whether they have side effects from the vaccine and do develop antibodies against the virus.
The participants in the test are split into two teams of 15 people, one of which will receive more vaccine than the other. Each person will receive two intramuscular injections.
If the first phase of testing a potential vaccine to confirm its safety for people, the second phase of the study will involve about 400 people.
In the case of test success Anges Inc. hopes among spring and fall 2021 to obtain from the Japanese government authorized the sale of vaccines against coronavirus.
Flash coronavirus infection COVID-19 began in late 2019 in China. March 11, 2020, the world health organization declared the spread of the coronavirus pandemic.
Who believe that the coronavirus would pose a serious threat, until they invent a vaccine. According to the head of the European Agency of medicines Marco Kavaleri, in the best case, the vaccine will be ready next year. May 15, U.S. President Donald trump suggested that the coronavirus vaccine can be developed and tested by the end of 2020.
Currently about 120 trials of a vaccine against coronavirus SARS-COV-2 / COVID-19 worldwide.